Taiwanese Study Shows New Technology Nearly Three Times Better at Healing Diabetic Foot Ulcers

| Apr 10, 2011

Taiwanese researchers say that a technology that uses sound waves to stimulate healing in diabetic foot ulcers is almost three times more effective than conventional hyperbaric oxygen therapy (HBOT). The technology, called dermaPACE®, is manufactured by SANUWAVE Health Inc., a medical device company located in Alpharetta, Ga.

If the study results can be duplicated, the new therapy would be a significant new tool for the treatment of diabetic foot ulcers. The malady is one of the leading causes of the estimated 80,000 foot, toe, and leg amputations that U.S. hospitals conduct each year. Loss of sensation in nerves that have been deadened by diabetic inflammation often leads to severe undetected foot injuries that are slow to heal and prone to infection.

The randomized study, conducted at Chang Gung Memorial Hospital in Kaohsiung, Taiwan, tracked 77 patients who had chronic, non-healing diabetic foot ulcers of at least three months duration. The wounds, mostly grade III and IV on the Wagner Ulcer Classification Scale, often were infected, had pus, bone inflammation, and even gangrene. The patients were considered at risk for eventual surgery, including possible amputation.

Thirty-nine patients, with 44 diabetic foot ulcers among them, were treated with dermaPACE, while the remaining 38 patients, with 40 diabetic foot ulcers among them, received conventional HBOT therapy. The dermaPACE group received two 20-minute procedures weekly over a three-week period (two hours total). The HBOT group received five 90-minute treatments weekly for eight weeks (60 hours total). Aside from their different therapies, patients received exactly the same standard wound care treatment after each session.

The study included a second course of treatment for patients whose ulcers did not improve under either therapy during the first session.

Results from the study showed a distinct difference in results between the two therapies:
Overall, 57 percent of the diabetic foot ulcers in the dermaPACE group completely healed, versus 25 percent in the HBOT group.
After one course of treatment, dermaPACE completely healed 24 ulcers, compared with 10 ulcers using HBOT.
After a second course of treatment, dermaPACE completely healed a combined 31 ulcers, compared with 11 ulcers for HBOT.
Sixty percent of ulcers treated with HBOT remained unchanged in size and depth, compared with 11 percent of ulcers treated with dermaPACE. Eight ulcers-47 percent-in the HBOT group showed no clinical improvement after a second course of treatment, while only one ulcer (seven percent) remained unchanged in the dermaPACE group.
Researchers noted a great difference in the time and sessions required for the two therapies: dermaPACE required only 15 percent as many sessions as HBOT and only three percent as much time.


How the Two Therapies Work

The difference between the two therapies is large. In HBOT, therapists subject a wound to high levels of oxygen under pressure. Many bacteria cannot metabolize when oxygen levels are high. That inability slows or blocks their reproduction, lessening infection and giving wounds a chance to heal. But the treatment, while it can slow deterioration in a diabetic foot ulcer, in many instances does not lead to total healing.

The process used by the dermaPACE device is "Paced Acoustic Cellular Expression," where high-energy sound waves are directed at the ulcer. The waves, which reach the wound like a shock wave, create stresses that actually stimulate the growth of new blood vessels and an inflammatory response that induces healing. Diabetic foot ulcers are so-called chronic conditions, in which the body has ceased responding urgently to the wound. By inducing an inflammatory response, dermaPACE turns the condition into an acute one where the body starts a robust healing process.

One outcome of that accelerated bodily response is increased perfusion, a term that means increased blood flow, which is crucial to the healing of a chronic wound. In the Taiwan study, perfusion increased 27 percent in the dermaPACE group after treatment, while perfusion remained statistically unchanged in the HBOT group.

The abstract of the study is available online at the Diabetes Research and Clinical Practice website.

Click Here To View Or Post Comments

Categories: Complications & Care, Diabetes, Diabetes, Foot Care, Foot ulcers, Health, Health Care, Research, Research, Type 1 Issues, Type 2 Issues, Wound Care, Wounds


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.